ROCHESTER, Minn. — Researchers at Mayo Clinic have demonstrated in a mouse model that their recently developed synthetic peptide carrier is a potential delivery vehicle for brain cancer ...

CAMBRIDGE, Mass., and ROCHESTER, Minn. - Today, Mayo Clinic and nference launch a startup company for drug development that will be powered by clinical expertise and artificial intelligence (AI).

An experimental drug designed to block an overactive protein ... When examining human samples of kidney cancer, researchers at Mayo Clinic's Florida campus discovered that one protein--produced ...

Two popular health-care trends, telemedicine and promising new weight-loss drugs, continue to converge. The Mayo Clinic on Tuesday announced a new telehealth service that will offer direct access ...

A study published in Brain Communications highlights a new approach to treating drug-resistant epilepsy. Researchers at Mayo Clinic have developed an innovative deep brain stimulation (DBS ...

Mayo Clinic has signed up to support development of InSitu Biologics’ prolonged-release drug delivery technology for anti-cancer therapeutics. The agreement gives Mayo a financial interest in ...